» Articles » PMID: 20960514

Human Embryonic Stem Cells Suffer from Centrosomal Amplification

Overview
Journal Stem Cells
Date 2010 Oct 21
PMID 20960514
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Propagation of human embryonic stem cells (hESCs) in culture tends to alter karyotype, potentially limiting the prospective use of these cells in patients. The chromosomal instability of some malignancies is considered to be driven, at least in part, by centrosomal overamplification, perturbing balanced chromosome segregation. Here, we report, for the first time, that very high percentage of cultured hESCs has supernumerary centrosomes during mitosis. Supernumerary centrosomes were strictly associated with an undifferentiated hESC state and progressively disappeared on prolonged propagation in culture. Improved attachment to culture substratum and inhibition of CDK2 and Aurora A (key regulators of centrosomal metabolism) diminished the frequency of multicentrosomal mitoses. Thus, both attenuated cell attachment and deregulation of machinery controlling centrosome number contribute to centrosomal overamplification in hESCs. Linking the excessive number of centrosomes in mitoses to the ploidy indicated that both overduplication within a single cell cycle and mitotic failure contributed to generation of numerical centrosomal abnormalities in hESCs. Collectively, our data indicate that supernumerary centrosomes are a significant risk factor for chromosome instability in cultured hESCs and should be evaluated when new culture conditions are being implemented.

Citing Articles

Embryonic stem cells overexpressing high molecular weight FGF2 isoform enhance recovery of pre-ganglionic spinal root lesion in combination with fibrin biopolymer mediated root repair.

Lima B, Cartarozzi L, Kyrylenko S, Ferreira Jr R, Barraviera B, Oliveira A Stem Cell Res Ther. 2024; 15(1):63.

PMID: 38438875 PMC: 10913678. DOI: 10.1186/s13287-024-03676-6.


Gains of 20q11.21 in human pluripotent stem cells: Insights from cancer research.

Krivec N, Ghosh M, Spits C Stem Cell Reports. 2023; 19(1):11-27.

PMID: 38157850 PMC: 10828824. DOI: 10.1016/j.stemcr.2023.11.013.


Scalable manufacturing of clinical-grade differentiated cardiomyocytes derived from human-induced pluripotent stem cells for regenerative therapy.

Morita Y, Kishino Y, Fukuda K, Tohyama S Cell Prolif. 2022; 55(8):e13248.

PMID: 35534945 PMC: 9357358. DOI: 10.1111/cpr.13248.


The frequency and consequences of multipolar mitoses in undifferentiated embryonic stem cells.

Pospisilova V, Esner M, Cervenkova I, Fedr R, Tinevez J, Hampl A J Appl Biomed. 2021; 17(4):209-217.

PMID: 34907719 DOI: 10.32725/jab.2019.018.


Mechanisms involved in selecting and maintaining neuroblastoma cancer stem cell populations, and perspectives for therapeutic targeting.

Farina A, Cappabianca L, Zelli V, Sebastiano M, Mackay A World J Stem Cells. 2021; 13(7):685-736.

PMID: 34367474 PMC: 8316860. DOI: 10.4252/wjsc.v13.i7.685.